High-mobility group protein 1(Y): Metastasis-associated or metastasis-inducing?

Journal of Surgical Oncology

Volumn 88, Issue 2, 2004, Pages 86-99

  Evans, Alice ^a   Lennard, Thomas W J ^a   Davies, Barry R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

HMG 1(Y); Metastasis; Tumorigenesis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP A1A PROTEIN; MESSENGER RNA;

BREAST CANCER; CANCER; CANCER MODEL; CANCER MORTALITY; CANCER THERAPY; CARCINOGENESIS; COLORECTAL CANCER; GENETIC TRANSCRIPTION; HUMAN; LYMPHOMA; METASTASIS; MORBIDITY; NEUROBLAST; NEUROBLASTIC CANCER; NONHUMAN; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; STOMACH CANCER; THYROID CANCER; UTERINE CERVIX CANCER; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL COMMUNICATION; CELL CYCLE; CHEMISTRY; COLORECTAL TUMOR; FEMALE; GENETICS; MALE; NEOPLASM; NEUROBLASTOMA; ONCOGENE; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL CYCLE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HMGA1A PROTEIN; HUMANS; LYMPHOMA; MALE; NEOPLASM METASTASIS; NEOPLASMS; NEUROBLASTOMA; ONCOGENES; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 7944236575     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20136     Document Type: Review

References (57)

1. Henry JM, Isaacs JT: Relationship between tumour size and the curability of metastatic prostate cancer by surgery alone or in combination with adjuvant chemotherapy. J Urol 1988;139: 1119-1123.
2. Kohn EC: Development and prevention of metastasis. Anticancer Res 1993;13:2553-2559.
3. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
4. Fidler U: Tumour heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978;38:2651-2660.
5. Sleeman JP: The lymph node as a bridgehead in the metastatic dissemination of tumours. Recent Results Cancer Res 2000;157: 55-81.
6. Liotta LA: Tumour invasion and metastasis - Role of the extracellular matrix. Cancer Res 1986;46:1-7.
7. Battista S, De Nigris F, Fedele M, et al.: Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene 1998;17:377-385.
8. Vallone D, Battista S, Pierantoni GM, et al.: Neoplastic transformation of rat thyroid cells requires the junB and fra-gene induction which is dependent on the HMG1-C gene product. EMBO J 1997;16:5310-5321.
9. Johnson KR, Lehn DA, Elton TS, et al.: Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-1(Y). J Biol Chem 1988;263: 18338-18342.
10. Johnson KR, Lehn DA, Reeves R: Alternative processing of mRNA's encoding mammalian chromosomal high-mobility-group proteins HMG-1 and HMG-Y. Mol Cell Biol 1989;9: 2114-2123.
11. Friedmann M, Holth LT, Zoghbi HY, et al.: Organization, inducible-expression and chromosome localization of the human HMG-1(Y) nonhistone protein gene. Nucleic Acids Res 1993;21: 4259-4267.
12. Chiappetta G, Avantaggiato V, Visconti R, et al.: High level of expression of the HMG1(Y) gene during embryonic development. Oncogene 1996;13:2439-2446.
13. Giancotti V, Buratti E, Perissin L, et al.: Analysis of HMG1 nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 1989;184:538-545.
14. Goodwin GH, Cockerill PN, Kellam S, et al.: Fractionation by high-performance liquid chromatography of the low-molecular-mass high-mobility-group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus transformed cells. Eur J Biochem 1985; 149:47-51.
15. Giancotti V, Pani B, D'Andrea P, et al.: Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J 1987;6:1981-1987.
16. Johnson KR, Disney JE, Wyatt CR, et al.: Expression of mRNAs encoding mammalian chromosomal proteins HMG-1 and HMG-Y during cellular proliferation. Exp Cell Res 1990;187: 69-76.
17. Ogram SA, Reeves R: Differential regulation of a multi-promotor gene: Selective 12-O-tetradecanolphorbol-13-acetate induction of a single transcription start site in the HMG-1/Y gene. J Biol Chem 1995;270:14235-14242.
18. Holth LT, Thorlacius AE, Reeves R: Effects of epidermal growth factor and estrogen on the regulation of HMG-1/Y gene in human mammary epithelial cell lines. DNA Cell Biol 1997; 16:1299-1309.
19. Bagga C, Michalowski S, Sabnis R, et al.: HMG1/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Res 2000;28: 2541-2550.
20. Lewis H, Kaszubska W, DeLamarter JF, et al.: Cooperativity between two NF-kB complexes, mediated by high-mobility-group protein 1(Y), is essential for cytokine-induced expression of the E-selectin promotor. Mol Cell Biol 1994;14:5701-5709.
21. Fashena SJ, Reeves R, Ruddle NH: A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumour-necrosis factor-β) gene regulation. Mol Cell Biol 1992;12:894-903.
22. Thanos D, Maniatis T: The high mobility group protein HMG-1(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 1992;71:777-789.
23. Brunetti A, Manfioletti G, Chiefari E, et al.: Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMG1(Y). FASEB 2001;15:492-500.
24. Baldassarre G, Battista S, Belletti B, et al.: Negative regulation of BRCAl gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003;23:2225-2238.
25. Reeves R, Edberg DD, Li Y: Architectural transcription factor HMG1(Y) promotes tumour progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 2001;21: 575-594.
26. Cmarik JL, Li Y, Ogram SA, et al.: Tumour promotor induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells. Oncogene 1998; 16:3387-3396.
27. Wood LJ, Mukherjee M, Dolde CE, et al.: HMG-1/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol 2000;20: 5490-5502.
28. Tamimi Y, Van Der Poel HG, Karthaus HF, et al.: A retrospective study of high mobility group protein 1(Y) as progression marker for prostate cancer determined by in situ hybridization. Br J Cancer 1996;74:573-578.
29. Bussemakers MJG, Van de Ven WJM, Debruye FM, et al.: Identification of high mobility group protein 1(Y) as a potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 1991;51:606-611.
30. Leman ES, Madigan MC, Brunagel G, et al.: Nuclear matrix localization of high mobility group protein 1(Y) in a transgenic mouse model for prostate cancer. J Cell Biochem 2003;88:599-608.
31. Nestl A, Von Stein OD, Zatloukal K, et al.: Gene expression patterns associated with the metastatic phenotype in rodent and human tumours. Cancer Res 2001;61:1569-1577.
32. Fedele M, Bandiera A, Chiappetta G, et al.: Human colorectal carcinomas express high levels of high mobility group HMG1(Y) proteins. Cancer Res 1996;56:1896-1901.
33. Kim D-H, Park Y-S, Park CJ, et al.: Expression of the HMG1(Y) gene in human colorectal cancer. Int J Cancer 1999;84:376-380.
34. Abe N, Watanabe T, Sugiyama M, et al.: Determination of high mobility group 1(Y) expression level in colorectal neoplasias: A potential diagnostic marker. Cancer Res 1999;59:1169-1174.
35. Chiappetta G, Manfioletti G, Pentimalli F, et al.: High mobility group HMG1(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int J Cancer 2001;91: 147-151.
36. Bandiera A, Bonifacio D, Manfioletti G, et al.: Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res 1998;58:426-431.
37. Giannini G, Kim CJ, Di Marcotullio L, et al.: Expression of the HMG1(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br J Cancer 2000;83:1503-1509.
38. Giannini G, Di Marcotullio L, Ristori E, et al.: HMG1(Y) and HMG1-C genes are expressed in neuroblastoma cell lines and tumours and affect retinoic acid responsiveness. Cancer Res 1999;59:2484-2492.
39. Abe N, Watanabe T, Izumisato Y, et al.: Diagnostic significance of high mobility group 1(Y) protein expression in intraductal papillary mucinous tumors of the pancreas. Pancreas 2002;25:198-204.
40. Abe N, Watanabe T, Masaki T, et al.: Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res 2000;60:3117-3122.
41. Tarbe N, Evtimova V, Burtscher H, et al.: Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumour model reveals metastasis-associated genes. Anticancer Res 2001;21: 3221-3228.
42. Chiappetta G, Bandiera A, Berlingieri MT, et al.: The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 1995;10:1307-1314.
43. Chiappetta G, Tallini G, De Biasio MC, et al.: Detection of high mobility group I HMG1(Y) protein in the diagnosis of thyroid tumours: HMG1(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 1998;58:4193-4198.
44. Xiang YY, Wang DY, Tanaka M, et al.: Expression of high-mobility group-ImRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa. Int J Cancer 1997;74:1-6.
45. Wood LJ, Maher JF, Bunton TE, et al.: The oncogenic properties of the HMG-1 family. Cancer Res 2000;60:4256-4261.
46. Ram TG, Reeves R, Hosick HL: Elevated high mobility group-1 (Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res 1993;53: 2655-2660.
47. Dolde CE, Mukherjee M, Cho C, et al.: HMG-1/Y in human breast cancer cell lines. Breast Cancer Res Treat 2002;71:181-191.
48. Tallini G, Dal Cin P: HMG1(Y) and HMG1-C dysregulation: A common occurrence in human tumours. Adv Anat Pathol 1999; 6:237-246.
49. Tallini G, Vanni R, Manfioletti G, et al.: HMG1-C and HMG1(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMG1-C and HMG1(Y) genes. Lab Invest 2000;80:359-369.
50. Klotzbucher M, Wasserfall A, Fuhrmann U: Misexpression of wild-type and truncated isoforms of the high-mobility group 1 proteins HMG1-C and HMG1(Y) in uterine leiomyomas. Am J Pathol 1999;155:1535-1542.
51. Nacht M, Ferguson AT, Zhang W, et al.: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 1999;59: 5464-5470.
52. Liu WM, Guerra-Vladusic FK, Kurakata S, et al.: HMG-1(Y) recognizes base-unpairing regions of matrix attachment sequences its increased expression is directly linked to the metastatic breast cancer phenotype. Cancer Res 1999;59:5695-5703.
53. Tamimi Y, Van Der Poel HG, Denyn MM, et al.: Increased expression of high mobility group protein 1(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 1993;53:5512-5516.
54. Takaha N, Hawkins AL, Griffin CA, et al.: High mobility group protein 1(Y): A candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res 2002;62: 647-651.
55. Kim SJ, Ryu J-W, Choi DS: The expression of the high mobility group 1(Y) mRNA in thyroid cancers: Useful tool of differential diagnosis of thyroid nodules. Korean J Intern Med 2000;15:71-75.
56. Scala S, Portella G, Fedele M, et al.: Adenovirus-mediated suppression of HMG-1(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci USA 2000; 97:4256-4261.
57. He Q, Liang CH, Lippard SJ: Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. PNAS 2000;97:5768-5772.